CARDIFF ONCOLOGY, INC. Number of Operating Segments
CARDIFF ONCOLOGY, INC. (CRDF) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:NumberOfOperatingSegments · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- CARDIFF ONCOLOGY, INC. number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
- CARDIFF ONCOLOGY, INC. number of operating segments for fiscal 2021 was 1.00 segment, a 0.00% change from fiscal 2020.
- CARDIFF ONCOLOGY, INC. number of operating segments for fiscal 2020 was 1.00 segment, a 0.00% change from fiscal 2019.
segment
| Period end | Number of Operating Segments 12 month |
|---|---|
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-29 |
| 2022-12-31 | 1.00 segment 10-K · filed 2023-03-02 |
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-24 |
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-25 |
| 2019-12-31 | 1.00 segment 10-K · filed 2020-02-27 |
Segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-07-29 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |